Daewon Pharmaceutical Co., Ltd.

ACTIVE

386 Cheonho-daero, Seongdong-gu, Seoul, 首尔特别市, South Koreawww.daewonpharm.comPublic1,222 employeesEstablished: 1958-01-07

Clinical Trials

5 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1958

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

41.7%

Phase 3

39.6%

Phase 2

8.3%

Phase 4

8.3%

Trial Status Distribution

Completed

70.8%

Enrolling By Invitation

2.1%

Not yet recruiting

8.3%

Recruiting

4.2%

Unknown

14.6%

Clinical Trials

Trials sponsored by this organization (48)

Multiple Ascending Dose Study of DW4421

Phase 1

Not yet recruiting

interventional

Sep 202656 participants

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Phase 1

Not yet recruiting

interventional

Mar 202638 participants

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

Phase 1

Not yet recruiting

interventional

Feb 202636 participants

Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers

Phase 1

Not yet recruiting

interventional

Feb 202648 participants

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

Phase 1

Enrolling By Invitation

interventional

Dec 202538 participants

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

Phase 1

Recruiting

interventional

Dec 2025150 participants

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

Phase 1

Completed

interventional

May 202555 participants

Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Phase 3

Completed

interventional

Apr 2025184 participants

Page 1 of 6

Approvals

No approval data available

News

No news articles found

Back to Organizations